| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2026 Q2 | Jul 21, 2026 | Baillie Gifford -International Concentrated Growth | - | -5.7% | 000660 KS, 300750.SZ, ASML, BNTX, DHER.DE, KER.PA, LONN SW, MELI, SPOT, TSM | AI, Concentration, E-Commerce, growth, international, long-term, semiconductors, technology | 300750.SZ LONN.SW 000660.KS ASML TSM SPOT MELI |
View | |
| 2026 Q1 | Apr 18, 2026 | Baillie Gifford – US Equity Growth | -6.0% | - | 6920.T, ADYEN.AS, AI.PA, ASML, LONN SW, MBLY, OR.PA, SIK.SW, SPOT, TSM | AI, growth, international, long-term, Quality, semiconductors, technology | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Fund Letters | Dr. Hendrik Leber | Lonza Group AG | Health Care | Life Sciences Tools & Services | Bull | Swiss Exchange | acquisition, biologics, capacity expansion, CDMO, Integration, Management Change | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||